Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000819050-21-000103
Filing Date
2021-07-19
Accepted
2021-07-19 16:29:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a20210719424b5preliminaryp.htm 424B5 388111
2 bbilogohr.jpg GRAPHIC 71984
  Complete submission text file 0000819050-21-000103.txt   488437
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254037 | Film No.: 211098231
SIC: 2836 Biological Products, (No Diagnostic Substances)